STOCKHOLM, SE / ACCESS Newswire / April 23, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drugs, ...

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

Increasing the ratio of potassium to sodium in the diet may be more effective for lowering blood pressure than simply ...

The NEET UG syllabus includes Physics, Chemistry and Biology (Botany and Zoology). Candidates can download the latest NEET ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors ...

In clinical studies of irbesartan there was no relationship between the dosage and the overall frequency of adverse reactions. The rates of serious adverse events were similar for irbesartan (1.0% ...

Salt Lake City, US-based Recursion will absorb its smaller UK counterpart as a result of the deal, which it said would create a "full-stack technology-enabled small molecule discovery platform ...

The antihypertensive drugs applied for adjustment were diuretics (thiazides, thiazide-like agents and loop diuretics), β-blockers, vasodilators (calcium-channel blockers and α-blockers) and inhibitors ...